Signed in as:

filler@godaddy.com

Hello

Welcome TO OUR LIBRARY

There's much to see here. We are sharing "hot", recent publications in the field of theranostics. So, take your time, look around, and learn. We hope you enjoy our library. More to come!

Lutetium

image14

Current Status of 177 Lu-PSMA Targeted Therapies and Where Will We Be In the Near Future

image15

ESMO 2019: Preliminary Results of a Phase I/II Dose-escalation Study of Fractionated Dose 177Lu-PSMA-617 for Progressive mCRPC

image16

Phase I/II Trial of Lutetium-177–PSMA-617 Plus Idronoxil in Metastatic Castration-Resistant Prostate Cancer

image17

PSMA PET During Lu-177–PSMA Radioligand Therapy May Help Guide Treatment

image18

Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer

Actinium

image19

225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

image20

Advances in targeted alpha therapy for prostate cancer

image21

225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience

image22

Clinical Experience on 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients: Safety and Efficacy Results

image23

Safety and Efficacy of Ac-225-PSMA-617 in mCRPC after Failure of Lu-177-PSMA

IODINE

image24

Iodine Symporter Targeting with 124I/131I Theranostics

image25

¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications

image26

MIBG in Neuroblastoma Diagnostic Imaging and Therapy.

ZIRCONIUM

image27

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients

image28

Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer

image29

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

image30

89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry

Thank you for visiting our Library.

Knowledge is important in our business, we strive for the highest level of excellence in our business, service, and competencies. Feel free to reach out if you want more information.